» Articles » PMID: 27401639

Development of Advanced Atherosclerotic Plaque by Injection of Inflammatory Proteins in a Rabbit Iliac Artery Model

Overview
Journal Yonsei Med J
Specialty General Medicine
Date 2016 Jul 13
PMID 27401639
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Appropriate animal models of atherosclerotic plaque are crucial to investigating the pathophysiology of atherosclerosis, as well as for the evaluation of the efficacy and safety of vascular devices. We aimed to develop a novel animal model that would be suitable for the study of advanced atherosclerotic lesions in vivo.

Materials And Methods: Atherosclerotic plaque was induced in 24 iliac arteries from 12 rabbits by combining a high cholesterol diet, endothelial denudation, and injection into the vessel wall with either saline (n=5), olive oil (n=6), or inflammatory proteins [n=13, high-mobility group protein B1 (HMGB1) n=8 and tumor necrosis factor (TNF)-α n=5] using a Cricket™ Micro-infusion catheter. Optical coherence tomography (OCT) was performed to detect plaque characteristics after 4 weeks, and all tissues were harvested for histological evaluation.

Results: Advanced plaque was more frequently observed in the group injected with inflammatory proteins. Macrophage infiltration was present to a higher degree in the HMGB1 and TNF-α groups, compared to the oil or saline group (82.1±5.1% and 94.6±2.2% compared to 49.6±14.0% and 46.5±9.6%, p-value<0.001), using RAM11 antibody staining. On OCT, lipid rich plaques were more frequently detected in the inflammatory protein group [saline group: 2/5 (40%), oil group: 3/5 (50%), HMGB1 group: 6/8 (75%), and TNF-α group: 5/5 (100%)].

Conclusion: These data indicate that this rabbit model of atherosclerotic lesion formation via direct injection of pro-inflammatory proteins into the vessel wall is useful for in vivo studies investigating atherosclerosis.

Citing Articles

Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling.

Lee S, Kim D, Lee J, Lee H, Moon R, Lee Y BMC Med. 2022; 20(1):309.

PMID: 36068525 PMC: 9450279. DOI: 10.1186/s12916-022-02485-z.


PAMPs and DAMPs as the Bridge Between Periodontitis and Atherosclerosis: The Potential Therapeutic Targets.

Zhu X, Huang H, Zhao L Front Cell Dev Biol. 2022; 10:856118.

PMID: 35281098 PMC: 8915442. DOI: 10.3389/fcell.2022.856118.


Anti-Inflammatory Effect for Atherosclerosis Progression by Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor in a Normoglycemic Rabbit Model.

Lee S, Lee S, Lee J, Kim J, Lee O, Kim C Korean Circ J. 2020; 50(5):443-457.

PMID: 32153145 PMC: 7098824. DOI: 10.4070/kcj.2019.0296.


Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis.

Lee S, Lee S, Thuy N, Kim J, Lee J, Lee O PLoS One. 2019; 14(5):e0215604.

PMID: 31050669 PMC: 6499436. DOI: 10.1371/journal.pone.0215604.


Macrophage polarization and acceleration of atherosclerotic plaques in a swine model.

Lee S, Oh J, Bong S, Kim J, Park S, Kim S PLoS One. 2018; 13(3):e0193005.

PMID: 29561847 PMC: 5862407. DOI: 10.1371/journal.pone.0193005.


References
1.
Granada J, Kaluza G, Wilensky R, Biedermann B, Schwartz R, Falk E . Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research. EuroIntervention. 2009; 5(1):140-8. DOI: 10.4244/eijv5i1a22. View

2.
Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, Sanvito F . Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J. 2006; 20(14):2565-6. DOI: 10.1096/fj.06-5867fje. View

3.
Phinikaridou A, Hallock K, Qiao Y, Hamilton J . A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res. 2009; 50(5):787-97. PMC: 2666165. DOI: 10.1194/jlr.M800460-JLR200. View

4.
Arbab-Zadeh A, Nakano M, Virmani R, Fuster V . Acute coronary events. Circulation. 2012; 125(9):1147-56. PMC: 3322378. DOI: 10.1161/CIRCULATIONAHA.111.047431. View

5.
Ridker P, Luscher T . Anti-inflammatory therapies for cardiovascular disease. Eur Heart J. 2014; 35(27):1782-91. PMC: 4155455. DOI: 10.1093/eurheartj/ehu203. View